Document is current
Any future updates will be listed below
-
Authors
Tripathi, Shailendra Mohan https://orcid.org/0000-0002-2134-5310
McNeil, Christopher J.
Staff, Roger T.
Murray, Alison D.
Wischik, Claude M.
Schelter, Bjoern
Waiter, Gordan D.
-
Funding
Funding for this research was provided by:
TauRx Pharmaceuticals (TauRx Pharmaceuticals)
- License Information
-
More Information
Article History
Received: 11 September 2024
Revised: 29 January 2025
Accepted: 31 January 2025
First Online: 24 February 2025
Declarations
:
: The study involves the human participants. Written informed consent was obtained from every participant before enrolment in the Studies TRx-237-015 (clintrials.gov NCT01689246) and TRx-237-005 (clintrials.gov NCT01689233. Consent for the patients lacking decision-making capacity was provided by legal representatives.
: The participants signed consent regarding publishing their data.
: The FDG-PET data was taken from participants of two large phase III clinical trials sponsored by TauRx Therapeutics (Singapore).
: Shailendra Mohan Tripathi was funded PhD studentship by TauRx Therapeutics and filed.two patents namely Tripathi, S.M., Miller, C., Murray, A.D., Wischik, C.M., Schelter, B.O., Waiter, G. (2022) Diagnosis of dementia. Indian patent application No. 202211035327; filed 20.06.2022 [also filed as PCT/EP2023/065075, 06.06.2023 and Taiwan application No. 112121404, 08.06.2023] &Tripathi, S.M., Murray, A.D., Staff, R.T. Shiells, H., Schelter, B.O. (2023) Treatment for disease. Indian patent application No. 202311014304; filed 03.03.2023. Roger T Staff, receives consulting fees from TauRx Therapeutics Ltd. Claude M. Wischik, own equity in TauRx Therapeutics Ltd and serving as Chief Executive Officer of TauRx Therapeutics Ltd. Inventor on several patents related to tau aggregation inhibition and synthesis. The patents are owned by WisTa Laboratories Ltd., a sister company of TauRx Therapeutics Ltd, and rights in these patents have been assigned to WisTa.Bjoen Schelter is a paid consultant and subject matter expert for TauRx. He is consultant in various aspects of data analytics and biostatistics. He is also co-inventor on various patents related to TauRx/GentingTauRxDiagnostics role. Christopher J. McNeil, Alison D. Murray and Gordon D. Waiter declare that they have no conflict of interest.
: During the preparation of this work the authors did not use generative AI and AI-assisted technologies. The authors take full responsibility for the content of this publication.
